Skip to Content

Regadenoson Pregnancy and Breastfeeding Warnings

Regadenoson is also known as: Lexiscan

Regadenoson Pregnancy Warnings

Use is not recommended unless clearly needed. US FDA pregnancy category: Not Assigned. Risk Summary: There is no data available regarding use in pregnant women to inform a drug-associated risk.

Animal studies have revealed increased embryofetal loss and fetotoxicity at doses that produced maternal toxicity. There are no controlled data in human pregnancy. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Regadenoson Breastfeeding Warnings

Based on the pharmacokinetics of this drug, it should be cleared 10 hours after administration.

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother; otherwise, the mother should pump and discard breast milk for 10 hours following administration of this drug. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Lexiscan (regadenoson)." Astellas Pharma US, Inc, Deerfield, IL.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. "Product Information. Lexiscan (regadenoson)." Astellas Pharma US, Inc, Deerfield, IL.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide